|
|
Organization, W. H., & Organisation mondiale de la santé. (1993). Assessing the standards of care in substance abuse treatment = Evaluation de la qualité des soins dans le traitement des toxicomanies. Geneva; Genève: World Health Organization (WHO); Organisation mondiale de la santé (OMS).
Keywords: treatment and maintenance
|
|
|
|
World Health Organization. (1990). Programme on substance abuse : the content and structure of methadone treatment programmes : a study in six countries (M. Gossop, & M. Grant, Eds.). World Health Organization (WHO).
Keywords: treatment and maintenance; outpatient care
|
|
|
|
Burkhart, G., Fegert, J. M., Schepker, R., Keller, F., Ludolph, A. G., Plener, P. L., et al. (2009). Preventing later substance use disorders in at-risk children and adolescents : a review of the theory and evidence base of indicated prevention (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Lisbon; Luxembourg: Office for Official Publications of the European Communities.
Abstract: This review on indicated prevention adds to the current knowledge and understanding of risk factors in the development of later drug problems and dependence, focusing on the mental health and behavioural problems that develop during childhood. Indicated prevention is a relatively new branch of drug prevention and can be seen as the third part of the ’prevention chain’, after universal and selective prevention. Its aim is not necessarily to prevent drug use or initiation to it, but rather to prevent the development of dependence, diminish frequency of use and avert ’dangerous’ patterns of substance use (e.g. moderate instead of binge-drinking).
Keywords: indicated prevention; AODD and AODR disorder; child; adolescent; childhood; risk factors; AOD use, abuse, and dependence
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2011). Report on the risk assessment of mephedrone in the framework of the council decision on new psychoactive substances. Risk assessments. Luxembourg: Office for Official Publications of the European Communities.
Abstract: This publication presents the summary findings and the conclusions of the risk assessment on mephedrone, carried out by the EMCDDA’s extended Scientific Committee, with participation of additional experts from the European Commission, Europol and the EMA. The risk assessment report, which was submitted to the European Commission and the Council of the European Union 26 May 2010, examines the health and social risks of the drug, as well as information on international trafficking and the involvement of organised crime. Furthermore, the report considers the potential implications for placing the drug under control in the EU. On the basis of this report – and on the initiative of the European Commission – on 2 December 2010, the Council decided that mephedrone is to be subject to control measures.
Keywords: psychoactive substances; mephedrone; monitoring; risk assessment; report; Europe
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2013). General report of activities 2012 : key achievements and governance : a year in review. General report of activities. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work.
Keywords: monitoring; AOD use, abuse, and dependence; psychoactive substances; AOD demand; intervention (persuasion to treatment); treatment and maintenance; epidemiology; AODR disorder; AODR mortality; research; administration and management; financial management; cost-effectiveness; quality control; assessment; evaluation; cooperation; collaboration; international area; Europe; European Monitoring Centre for Drugs and Drug Addiction (body); annual report; financial statement
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2013). EMCDDA-Europol Joint Report on a new psychoactive substance : 5-(2-aminopropyl)indole. Joint Reports. Luxembourg: Publications Office of the European Union.
Abstract: At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation ’5-IT’), through a joint assessment. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 5-(2-aminopropyl)indole as stipulated by Article 5.1 of the Council Decision 2005/387/JHA.
Keywords: psychoactive substances; benzodiazepines; designer drug; research chemical; AOD consumption; risk assessment; AOD intoxication; AODR mortality; AODR crime; government and politics; AOD public policy strategy; law enforcement; rave; Europe; European Union
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2013). Drug policy profiles : Ireland. Drug policy profiles. Lisbon: Publications Office of the European Union.
Abstract: The national drug policy of Ireland comes under the spotlight in the second volume in the EMCDDA series of Drug policy profiles. Examining the evolution of Irish drug policy through four periods of historic development, the report explores: the country’s national strategies; the legal context within which they operate; the public funds spent, or committed, to implement them; and the political bodies and mechanisms set up to coordinate the response to the problem. The profile sets this information in context by outlining the size, wealth and economic situation of the country as a whole, as well as the historical development of the current policy. Also described is the manner in which events in Ireland bear similarities with, and differences from, developments in other European countries.
Keywords: history; AOD public policy strategy; drug offense; law; drug legalization; evaluation; Ireland
|
|
|
|
Mounteney, J., Evans-Brown, M., & Giraudon, I. (2012). Fentanyl in Europe : EMCDDA trendspotter study : report from an EMCDDA expert meeting 9 to 10 October 2012. Technical reports. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, Prevalence, Consequences and Data Management Unit.
Abstract: The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9-10 October 2012. The aim of the study was to increase understanding of the availability and illicit use of fentanyl in Europe, with a specific focus on: the extent and patterns of use; illicit production and diversion; harms and deaths; and, responses to the problem. Twelve experts from 10 EU Member States (Bulgaria, Czech Republic, Germany, Estonia, Greece, Italy, Slovakia, Sweden, Finland, United Kingdom) attended the meeting, presenting their experiences and contributing to an analysis of the topic, providing insights from law enforcement, forensics, treatment, research and monitoring, and drug user perspectives.
Keywords: illicit drug; illegal drug use; fentanyl; AOD use pattern; AOD supply; AOD associated consequences; AODR mortality; public policy on AOD; treatment and maintenance; law enforcement; monitoring; statistical data; conference; international area; Europe; European Union
|
|
|
|
Thanki, D., Matias, J., Griffiths, P., Noor, A., Olszewski, D., Simon, R., et al. (2012). Prevalence of daily cannabis use in the European Union and Norway (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Publications Office of the European Union.
Abstract: This report brings together, for the first time in Europe, an integrated overview of the prevalence of intensive cannabis use, defined as daily or almost daily cannabis use (use on 20 or more days in the month preceding survey). Self-reported data regarding frequency of cannabis use from large, probabilistic, nationally representative samples of general population surveys from 20 countries, representing more than 83 % of the population of EU and Norway, were collected through two rounds of ad hoc data collection in 2004 and 2007 and through a routine, standard data collection instrument since 2010.
Keywords: AOD use, abuse, and dependence; AOD consumption; illicit drug; cannabis; prevalence; survey; statistical data; international area; Norway; Europe; European Union
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2012). EMCDDA strategy and work programme 2013-15. Work programmes and strategies. Luxembourg: Publications Office of the European Union.
Abstract: The 2013-15 strategy and work programme is the third one since the EMCDDA’s recast Regulation in 2006. It is built around three top-level commitments: (a) providing a relevant, timely and responsive analysis of the drug situation; (b) efficiency: deriving maximum value from activities and investments; (c) communication and a customer-orientated approach. The bedrock on which this three-year strategy and work plan rests is the recognition that the achievements the agency has made since its inception have been delivered by maintaining clarity of purpose, technical rigour and a long-term vision.
Keywords: administration and management; government and politics; communication; cooperation; risk assessment; AOD demand; database; AOD supply; monitoring; European Monitoring Centre for Drugs and Drug Addiction (body); international area; Europe
|
|
